WallStreetZenWallStreetZen

NASDAQ: EYPT
Eyepoint Pharmaceuticals Inc Stock Ownership - Who owns Eyepoint Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Eyepoint Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Cormorant Asset Management LP10% Owner2024-04-18395,244$17.62
$6.96MBuy
Cormorant Asset Management LP10% Owner2024-04-18186,521$18.90
$3.53MBuy
Dario A. PaggiarinoChief Medical Officer2024-03-3015,493$20.67
$320.24kSell
Dario A. PaggiarinoChief Medical Officer2024-03-307,096$20.67
$146.67kSell
Dario A. PaggiarinoChief Medical Officer2024-03-302,957$20.67
$61.12kSell
Dario A. PaggiarinoChief Medical Officer2024-02-092,565$28.80
$73.87kSell
George ElstonChief Financial Officer2024-02-091,734$28.80
$49.94kSell
David Scott JonesSVP Chief Commercial Officer2024-02-091,955$28.80
$56.30kSell
Nancy LurkerExecutive Vice Chair2024-02-096,981$28.80
$201.05kSell
Nancy LurkerExecutive Vice Chair2024-02-097,962$28.80
$229.31kSell

1 of 13

EYPT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EYPT insiders and whales buy or sell their stock.

EYPT Shareholders

What type of owners hold Eyepoint Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ew Healthcare Partners LP175.19%87,298,833$1.41BInsider
Pfizer Inc149.47%74,483,748$1.20BInsider
Ronald W. Eastman34.54%17,212,648$278.16MInsider
Cormorant Asset Management LP22.09%11,005,943$177.86MInsider
Cormorant Asset Management LP12.12%6,038,235$97.58MInstitution
Adage Capital Management LP10.35%5,156,299$83.33MInsider
Franklin Resources Inc9.31%4,640,651$74.99MInstitution
Adage Capital Partners GP LLC8.96%4,466,420$72.18MInstitution
Suvretta Capital Management LLC8.14%4,056,847$65.56MInstitution
Price T Rowe Associates Inc5.06%2,522,704$40.77MInstitution

1 of 3

EYPT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EYPT20.11%79.89%Net SellingNet Buying
RLAY72.36%27.64%Net SellingNet Selling
VRDN67.46%32.54%Net Buying
TYRA59.50%40.50%Net BuyingNet Buying
SAGE71.61%28.39%Net Selling
View Top Biotech Stocks

Eyepoint Pharmaceuticals Stock Ownership FAQ

Who owns Eyepoint Pharmaceuticals?

Eyepoint Pharmaceuticals (NASDAQ: EYPT) is owned by 99.47% institutional shareholders, 395.22% Eyepoint Pharmaceuticals insiders, and 0.00% retail investors. Ew Healthcare Partners LP is the largest individual Eyepoint Pharmaceuticals shareholder, owning 87.30M shares representing 175.19% of the company. Ew Healthcare Partners LP's Eyepoint Pharmaceuticals shares are currently valued at $1.41B.

If you're new to stock investing, here's how to buy Eyepoint Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.